The Alzheimer’s Research UK Conference 2023 took place 5-6th March in Aberdeen, UK. As the UK’s premier dementia research conference, ARUK brought us a packed program on cutting-edge research from leaders in the neurodegeneration field.

Explore our coverage for novel data and unique perspectives!

ARUK 2023

ARUK 2023

 

The Alzheimer’s Research UK Conference 2023 took place 5-6th March in Aberdeen, UK. As the UK’s premier dementia research conference, ARUK brought us a packed program on cutting-edge research from leaders in the neurodegeneration field.

Explore our coverage for novel data and unique perspectives!

Defining the microglia proteome and how it changes in Alzheimer’s disease 11:33
Defining the microglia proteome and how it changes in Alzheimer’s disease
Amy Lloyd • 3 Mar 2023
Establishing the UK DRI Biomarker Factory 5:59
Establishing the UK DRI Biomarker Factory
Amanda Heslegrave • 10 Feb 2023
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD 3:27
TDP-43 aggregation drives loss of UNC13A, a risk gene for ALS & FTD
Matthew Keuss • 17 Mar 2023
Understanding microglia heterogeneity and plasticity in health and disease 2:52
Understanding microglia heterogeneity and plasticity in health and disease
Amy Lloyd • 3 Mar 2023
How can researchers use the UK DRI Biomarker Factory? 6:19
How can researchers use the UK DRI Biomarker Factory?
Amanda Heslegrave • 10 Mar 2023
A future scenario: digital and blood biomarkers for Alzheimer’s disease diagnosis in primary care 4:34
A future scenario: digital and blood biomarkers for Alzheimer’s disease diagnosis in primary care
Michael Schöll • 16 Mar 2023
de novo proteins generated from cryptic exon translation in ALS & FTD 1:27
de novo proteins generated from cryptic exon translation in ALS & FTD
Matthew Keuss • 17 Mar 2023
Microglia phenotypic transitions in neurodegenerative diseases 3:35
Microglia phenotypic transitions in neurodegenerative diseases
Amy Lloyd • 3 Mar 2023
Current and future role of tau-PET in dementia daily practice 0:51
Current and future role of tau-PET in dementia daily practice
Michael Schöll • 16 Mar 2023
The content of VJDementia is intended for healthcare professionals